AlphaCrest Capital Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,390
Closed -$288K 23
2022
Q3
$288K Buy
10,390
+2,115
+26% +$68.6K 0.02% 1150
2022
Q2
$245K Buy
+8,275
New +$278K 0.01% 1166
2021
Q1
Sell
-14,500
Closed -$504K 1164
2020
Q4
$504K Buy
+14,500
New +$409K 0.04% 641
2019
Q4
Sell
-14,739
Closed -$338K 1234
2019
Q3
$338K Buy
+14,739
New +$336K 0.02% 1071

Other funds holding ADNT

AlphaCrest Capital Management's ADNT Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Adient (ADNT) in Q4 2022, closing a stake of 10,390 shares — an estimated $288K sold.

AlphaCrest Capital Management first reported a position in ADNT in Q3 2019 and held it in 4 quarters. The position peaked at $504K in Q4 2020. 274 funds tracked by Wall St. Rank hold ADNT as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Adient position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 10,390 Adient shares in Q4 2022, an estimated $288K.
  • AlphaCrest Capital Management first reported a position in Adient in Q3 2019 and held it in 4 quarters.
  • AlphaCrest Capital Management's Adient position peaked at $504K in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Adient as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.